immunophilin
isoimmunization
pancytokeratin
toll gene
immunome
immunoproteasomal
immunoglobulin E
immunosubversion
cytokine
immunoproteomics
allotype
ozogamicin
affitin
guselkumab
muromonab
cedelizumab
immunosubtyping
immunosubunit
isoallergenic
cibisatamab
immunoproteomic
radioimmunoreactivity
alloantibody
immunogen
chromobody
immunodominance
olendalizumab
immunoneutral
affibody
autoepitope
heterophilic
agonistic monoclonal antibody
immunopathology
vobarilizumab
immunotropism
alloactivation
atezolizumab
immunosubtype
olaratumab
antiarrestin
immunocarrier
alloantigen
radioimmunology
brolucizumab
immunopoiesis
immunohomeostasis
abagovomab
alloreaction
pidilizumab
immunocompatible
tislelizumab
gevokizumab
ravulizumab
immunosystem
immunorecessive
-lim-
immunohybridization
seroconversion
bioimmunoassay
-toxa-
immunonormal
immunoarchitecture
immunoexpress
immune
pozelimab
sasanlimab
solitomab
toripalimab
dinutuximab
ziltivekimab
immunoneutralization
immunocharacterization
enzymoimmunoassay
autoimmunology
presentation
sintilimab
zenocutuzumab
heteroclitic
immunobarrier
physiocrine
vanucizumab
fusokine
myddosome
retifanlimab
nonimmune
radioimmunoelectrophoresis
immunodefensive
immunophenotypically
robatumumab
isoagglutinogen
polyvalent
antiantibody
siltuximab
complement
immunoproliferation
immunostatus
immunologic
immunoenhancement
cergutuzumab
immunosorbance